Implementation of a Canadian Prescription Drug Importation Program

In accordance with Senate Bill 19-005, the Department of Health Care Policy & Financing (Department) will be developing an application to the U.S. Department of Health and Human Services (HHS) to establish a Canadian prescription drug importation program. The Federal Food Drug and Cosmetic Act (FDCA) Section 804 permits importation and reimportation of prescription drugs from Canada by a pharmacist or wholesaler, provided the drugs meet certain minimum standards, HHS certifies the program will pose no additional risk to the public’s health and safety, and results in a significant reduction in costs to consumers. The Department will be developing its application with stakeholder input and looks forward to working with partners in this effort.

Stakeholder Engagement Opportunities

Please take our Canadian Prescription Drug Importation Survey!

Stakeholder Presentation Slides -  November 13, 2019

November 12, 2019: Wholesalers Stakeholder Session - Cancelled

November 13, 2019: Pharmacies Stakeholder Session
3 to 5 p.m.
1570 Grant Street, Denver CO 80203
Hibiscus Conference Room

November 14, 2019: Manufacturers Stakeholder Session
3 to 5 p.m.
1570 Grant Street, Denver CO 80203
Hibiscus Conference Room

November 18, 2019: Consumers and Providers Stakeholder Session
Noon to 2 p.m.
1570 Grant Street, Denver CO 80203
Hibiscus Conference Room

Resources

Stay Informed

We encourage you to sign up for updates on our drug importation work. Please fill out the signup form to be added to our list.

We can also be contacted via email at HCPF_005DrugImportation@state.co.us.